01 January 2005
Chemoembolization and two-step hepatic resection to treat advanced unresectable metastatic carcinoid tumor
López-Tomassetti Fernández E.M, Martín Malagón A., Rodríguez Ballester L., Arteaga González ICase Rep Clin Pract Rev 2005; 6:341-346 :: ID: 440497
Abstract
Background: Resection of hepatic metastases of gastroenteropancreatic neuroendocrine tumors is possible in only 10% of cases and authentically curative in only 30%. Results usually depend on the
extent and distribution of the metastases at the time of the intervention. Transcatheter arterial
chemoembolization is an accepted palliative method (with great functional benefit for patients
with hypersecreting tumors) of nonresectable multiple bilobar metastases from endocrine tumors but it does not seem to have the efficacy of resectional therapy. Systemic chemotherapy and somatostatin analogues are other available options to treat non-surgically for long-term palliation of these patients.
Case Report: We describe the case of a 66 years-old man with multiple bilobar metastases from intestinal
carcinoid tumor treated succesfully with chemoembolization and two stage hepatic resection with
curative intention. His excellent response to chemoembolization permitted successful application
of an aggressive resectional approach.
Conclusions: Unresectable multilobular hepatic metastases from carcinoid tumor can occasionally be made resectable with preoperative chemoembolization.
Keywords: arterial chemoembolization, neuroendocrine tumor, hepatic metastases
SARS-CoV-2/COVID-19
19 May 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.936370
17 May 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.936651
13 May 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.936589
13 May 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.936574
In Press
23 May 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.935148
23 May 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.936704
23 May 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.936600
20 May 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.936826
Most Viewed Current Articles
23 Feb 2022 : Case report
DOI :10.12659/AJCR.935250
Am J Case Rep 2022; 23:e935250
17 Feb 2022 : Case report
DOI :10.12659/AJCR.934399
Am J Case Rep 2022; 23:e934399
06 Dec 2021 : Case report
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
19 Feb 2022 : Case report
DOI :10.12659/AJCR.935355
Am J Case Rep 2022; 23:e935355